ANSM : Agence nationale de sécurité du médicament et des produits de santé
Glossaire
|
Abonnement
|
Agenda
|
Newsletter
Produits de santé
L'ANSM
S'informer
Décisions
Activités
Dossiers
Publications
Services
Déclarer un effet indésirable
Recherche:
Date de publication
X
Plus d'un an
Rubrique
X
- Information in English
Résultats de votre recherche
167 résultats pour la recherche
Trier par:
Pertinence
-
Date
Notice to applicants for marketing for Temporary Authorisation for Use (ATU)
(05/08/2015)
Application of the Regulation (EU) on clinical trials on medicinal products: ANSM to implement a pilot phase - Information update
(14/04/2015)
Temporary Specialist Scientific Committee on inhibitors of the FAAH (Fatty Acid Amide Hydrolase)- 03/31/2016 - Summary of conclusion
(06/04/2016)
Report by the Temporary Specialist Scientific Committee (TSSC), "FAAH (Fatty Acid Amide Hydrolase)", on the causes of the accident during a Phase 1 clinical trial in Rennes in January 2016
(25/04/2016)
Implantable defibrillation leads - Inspection campaign summary report
(19/05/2016)
Enforcement of the european regulation on clinical trials on medicinal products : assesment six months into the pilot phase - Information bulletin
(19/04/2016)
Decision of 10/09/2015 setting out the specific conditions for the placing on the market and distribution of certain medical devices sterilised using ethylene oxide - Framework and implementation modalities
(19/02/2016)
Temporary Specialist Scientific Committee on inhibitors of the FAAH (Fatty Acid Amide Hydrolase) - Summary of conclusion
(17/02/2016)
Study on safety of medical devices software
(13/07/2016)
Situation report on the active substance amoxicillin
(26/09/2016)
Temporary Specialist Scientific Commity "Breast implant biocompatibility evaluation strategy" - 02/01/2016 -Meeting minutes
(06/07/2016)
Temporary Specialist Scientific Commity "Breast implant biocompatibility evaluation strategy" - 03/15/2016 -Meeting minutes
(06/07/2016)
Guideline for demonstrating textured breast implant biocompatibility
(06/07/2016)
Labelling relative to phthalates in a medical device - Notice to manufacturers
(11/10/2016)
Market surveillance of PVC medical devices presented DEHP-free - Report
(11/10/2016)
Toxicological evaluation of nanoparticle medicinal products (V2-04/11) - Recommendations
(17/11/2008)
Summary of the characteristics of a device (MD or IVD)
(19/05/2009)
Notice for sponsors - The installation and control in France of clinical trials relating to medical devices and in vitro diagnostic medical devices
(19/03/2008)
Denotification or termination of notified bodies’ activities - Information
(14/11/2016)
Enforcement of the European regulation on clinical trials on medicinal products : assessment one year into the pilot phase
(25/01/2017)
1
2
3
4
5
6
7
8
9
2017 - droit d'auteur ANSM
Ressources humaines
|
Marchés publics
|
Portail des agences sanitaires
|
Mentions légales
|
Plan du site
|
Contacts